Esophageal Stricture
19
2
2
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
15.8%
3 terminated out of 19 trials
66.7%
-19.8% vs benchmark
11%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (19)
Budesonide Following Endoscopic Dilatation of Esophageal Strictures in Children.
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Local Triamcinolone Injection Combined With Fibrin Glue Spray in Preventing Esophageal Stricture After Big-range Endoscopic Submucosal Dissection for Esophageal Early Cancer
Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms
Steroid Versus Mitomycin-C Use in Pediatric Benign Recurrent Esophageal Stricture
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures
Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures
Balloon Dilation Methods for Benign Esophageal Stricture
INGEST I Pilot Study
Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)
The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children
Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy
Cryoablation for Benign Gastrointestinal Anastomotic Strictures
Mitomycin-C Injection Therapy in Refractory Esophageal Stricture
EndoFLIP Use in Upper GI Tract Stenosis
Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm
Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children